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Aluminium (Al) is a neurotoxic metal that contributes to the progression of several neurodegenerative diseases. The aim 
of the present study was to evaluate the protective effect of dietary eugenol supplementation against aluminium (Al)-
induced cerebral damage in rats. Male Wistar rats were divided into four groups: normal controls, rats fed a diet containing 
6,000 μg g-1 eugenol, rats intoxicated daily with aluminium chloride (84 mg kg-1 body weight) p. o. and fed either a basal 
diet or a eugenol-containing diet. Daily oral administration of Al for four consecutive weeks to rats significantly reduced 
brain total antioxidant status (TAS) (11.42±0.31 μmol g-1 tissue, p<0.001) with a subsequent significant enhancement of 
lipid peroxidation (MDA) (32.55±1.68 nmol g-1 tissue, p<0.002). In addition, Al enhanced brain acetylcholinesterase 
activity (AChE) (46.22±4.90 U mg-1  protein,  p<0.001),  tumour  necrosis  factor  alpha  (TNF-α)  (118.72±11.32  pg 
mg-1 protein, p<0.001), and caspase 3 (Casp-3) (8.77±1.26 ng mg-1 protein, p<0.001) levels, and in contrast significantly 
suppressed brain-derived neurotrophic factor (BDNF) (82.74±14.53 pg mg-1 protein, p<0.002) and serotonin (5-HT) 
(1.54±0.12 ng mg-1 tissue, p<0.01) levels. Furthermore, decreased glial fibrillary acidic protein (GFAP) immunostaining 
was noticed in the striatum of Al-intoxicated rats, compared with untreated controls. On the other hand, co-administration 
of dietary eugenol with Al intoxication restored brain BDNF (108.76±2.64 pg mg-1 protein) and 5-HT 
(2.13±0.27 ng mg-1 tissue) to normal levels, enhanced brain TAS (13.43±0.24 μmol g-1 tissue, p<0.05), with a concomitant 
significant reduction in TNF-α (69.98±4.74 pg mg-1 protein) and Casp-3 (3.80±0.37 ng mg-1 protein) levels (p<0.001), as 
well as AChE activity (24.50±3.25 U mg-1 protein, p<0.001), and increased striatal GFAP immunoreactivity, compared 
with Al-treated rats. Histological findings of brain tissues verified biochemical data. In conclusion, eugenol holds potential 
as a neuroprotective agent through its hydrophobic, antioxidant, and anti-apoptotic properties, as well as its neurotrophic 
ability against Al-induced brain toxicity in rats.
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Aluminium (Al), the most abundant metal on earth that 
constitutes 8.13 % of the crust, may enter the human body 
through food, drinking water, and Al-containing drugs   (1, 
2). As a result of the wide usage of such a well-established 
neurotoxin (3-5), Al has become a global public health 
problem. Reports  have  also  defined  it  as  an  important 
etiological factor in the progression of several 
neurodegenerative disorders as it influences more than 200 
biologically important reactions (6, 7). Aluminium-induced 
brain toxicity was reported in rats by many authors, 
including administration of aluminium chloride hexahydrate 
(25 mg kg-1 day-1) for one month by oral gavage (8), daily 
oral treatment with aluminium chloride (100 mg kg-1) for 
42 days (2), or administration of aluminium chloride 
(17 mg kg-1 day-1) orally for four consecutive weeks (9, 10). 
The neurotoxicity of Al is likely to be the result of a 
combination of several mechanisms, including oxidative 
brain injury, induction of apoptosis and neuronal damage, 
neuroglia inflammatory reaction,  and reduced 
neurotransmitter biosynthesis (6, 11).
The pharmacological and therapeutic properties of 
medicinal plants have been attributed to different chemical 
constituents isolated from their crude extracts. Many 
naturally-occurring compounds were reported to prevent 
neural damage and become, therefore, important therapeutic 
candidates for brain disorders. Eugenol (4-allyl-1-hydroxy-
2-methoxybenzene), an effective antioxidant phenolic 
compound extracted from clove (Syzygium aromaticum), 
is one of these compounds (12). It is approved for use as a 
food additive by the U.S. Food and Drug Administration 
and is on the list of substances “generally recognised as 
safe”(13).
A wide range of pharmacological properties for eugenol 
in nephrotoxicity, chronic inflammation, cancer, as well as 
metastasis were demonstrated (14-17). In addition, eugenol 
was previously reported to protect neuronal cells from 
excitotoxic and oxidative injury in mouse cortical cultures 
(18). Furthermore, it prevented from 6-hydroxydopamine 
(6-OHDA)-induced neurotoxicity in mouse striatum (19) 
and provided a neuroprotective effect against hippocampal 
CA1 neuronal ischemia-induced injury in gerbils (20). It 
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also proved to protect against acrylamide-induced 
neuropathy (21) and chlorpyrifos-induced brain toxicity 
(12) in rats, which may at least in part be attributed to its 
antioxidative stress activity.
Considering the beneficial in vitro and in vivo effects 
of eugenol, including its antioxidant, cytotoxic, 
antiproliferative,  and  anti-inflammatory  properties,  the 
current study was undertaken to investigate the 
neuroprotective potential of eugenol against Al-induced 
cerebral damage in rats and to shed light on the underlying 
mechanisms involved in such protection. 
MATERIALS AND METHODS
Chemicals
Eugenol was  obtained  from Wako  Pure  Chemical 
Industries Ltd (Osaka, Japan) and aluminium chloride 
(AlCl3.6H2O; CAS No. 7784-13-6) was purchased from 
Loba Chemie (Mumbai, India). All other chemicals used 
were of analytical grade.
Animals
Adult male Wistar rats (eight weeks old) were obtained 
from the breeding unit of the Egyptian Stock Holding 
Company for Biological Products, Vaccines, Sera and Drugs 
(Helwan, Egypt). The animals were housed in plastic cages 
on wood-chip bedding and had free access to commercial 
pelleted diet and distilled water before the start of the 
experiment. They were acclimatised for one week. Animals 
were maintained in accordance with the Guide for the Care 
and Use of Laboratory Animals (22) and all applicable 
institutional guidelines were followed.
Experimental protocol
In total, 40 rats were randomly allocated to four equally 
sized groups (10 rats per group). Rats in the first group were 
assigned to a powdered basal AIN-93M diet (23) serving 
as the control group (Control), whereas the animals in the 
second  group  (EUG) were  administered  a  basal  diet 
containing eugenol  (6,000 μg g-1) (24). Rats in the third 
(AlCl3) and fourth (EUG+AlCl3) groups were administered 
AlCl3 (84 mg kg
-1 body weight equivalent to 17 mg ions of 
Al) p.o. daily using an intragastric tube for four consecutive 
weeks (25) and were assigned to the basal and eugenol-
containing (6,000 μg g-1) basal diets, respectively. Being 
used as a food additive in many products (ice cream, baked 
goods, gelatines, puddings, chewing gums, and meat 
products) (13), we thought it was better to administer 
eugenol through diet rather than a single bolus dose, 
especially as eugenol is rapidly absorbed and metabolised 
in the liver (26). Eugenol-containing diets were prepared 
once weekly by mixing eugenol with the powdered basal 
diet in a blender for 15 min, which was then stored at 4 °C 
in the dark (24). The diets were available ad libitum and 
were given to animals by freshly replenishing feed trays 
twice weekly, where food consumption was recorded. No 
mortalities were previously recorded in rats fed with diets 
containing eugenol (6,000-50,000 μg g-1) in a fourteen-day 
study (13). The lowest dose (6,000 μg g-1) was, therefore, 
previously selected (24) and herein adopted. As for 
aluminium, three doses were previously evaluated in rats 
(6, 17, and 50 mg kg-1) and the minimum effective dose of 
aluminium that induced a biological toxic effect was set at 
the level of 17 mg kg-1 (25), which was selected in the 
current study.
Tissue sampling
At the end of the four-week treatment period, rats were 
killed by cervical dislocation and the fore-brains (including 
the cerebral areas with hippocampus and striatum) were 
isolated on ice and then divided sagittally into two parts 
using a sharp blade. One part was stored in ice-cold sterile 
physiologic saline at -20 °C (seven hemispheres were kept 
for tissue homogenisation and three for trace metal 
analysis), while the other one was fixed in 10 % phosphate-
buffered formalin for 48 h for histological examination.
Preparation of brain homogenate
Fore-brains were made into 10 % homogenates with 
ice-cold physiologic saline using a glass homogeniser (27), 
and the homogenates were centrifuged at 1,800 g for 20 min 
at 4 °C (Sigma 2-16PK, SIGMA Laborzentrifugen GmbH, 
Osterode  am Harz,  Germany).  The  supernatant  was 
immediately separated on ice, aliquoted, and stored at 
-20 °C until further biochemical analysis.
Biochemical assays
Brain lipid peroxidation was measured in terms of 
malondialdehyde (MDA) using thiobarbituric acid (Sigma-
Aldrich Chemie Gmbh, Steinheim, Germany) (28). Total 
antioxidant status (TAS) was evaluated by a colorimetric 
method based on the ability of brain antioxidants to suppress 
the production of thiobarbituric acid reactive substances 
(TBARS). TBARS are released following benzoate 
degradation by means of hydroxyl radicals (•OH) that form 
in a Fenton-type reaction (29). Brain acetylcholinesterase 
activity (AChE) was determined colourimetrically (30) 
using a kit provided by Sigma-Aldrich (St Louis, MO, 
USA). Tumour necrosis factor alpha (TNF-α) concentration 
was measured in the brain homogenate using a rat TNF-α 
ELISA kit provided by R&D Systems (Minneapolis, MN, 
USA), whereas brain caspase 3 (Casp-3) level and brain-
derived neurotrophic factor (BDNF) concentrations were 
analysed using rat ELISA kits supplied by MyBioSource 
(MyBioSource, Inc., San Diego, CA, USA). The total 
protein level was determined in brain homogenates (31).
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Immunohistochemistry
Four micrometre-thick sections of fore-brains were 
incubated with mouse monoclonal antibody to glial 
fibrillary  acidic  protein Ab-1(GFAP;  1:500)  (Thermo 
Scientific, CA, USA). Sections were then incubated with 
horseradish peroxidase-conjugated goat anti-mouse 
secondary  antibody  (1:5,000)  (Thermo Scientific, CA, 




using the Levene’s test for homogeneity of variances and 
statistical analysis of the difference between the mean 
values was carried out using one-way analysis of variance 
(ANOVA) followed by the least significant difference (LSD) 
test  for multiple  comparisons.  SPSS  statistical  software 
22.0 for Windows (SPSS, Inc., Chicago, IL, USA) was used 
for all analyses. A value of p<0.05 was considered 
statistically significant for all tests.
RESULTS
Food consumption and average intake data
No mortality was recorded during the experimental 
study. As for eugenol, its acute toxicity is low when 
administered orally, with LD50 values ranging from 1,930 
to 2,680 mg kg-1 day-1 in rats (34, 35). Its sub-chronic 
toxicity is also low, with no observed adverse effect level 
(NOAEL) ranging from 900->2,000 mg kg-1 day-1. 
Furthermore, up to 1.0 % eugenol in the diet (10,000 μg g-1) 
did not cause adverse effects (26). On the other hand, the 
LD50 of aluminium chloride is reported to be 3,800 mg kg
-1 
(36) in rats. A non-significant change was recorded in food 
consumption among different groups (Table 1). Aluminium 
content in the basal diet of rats was found to be 16 μg g-1 
and based on food consumption data, the average intake of 
dietary Al in different groups ranged from 1.27 to 
1.56 mg kg-1 day-1. Rats fed eugenol-containing diets, either 
alone or intoxicated with Al, consumed 480 and 
580 mg kg-1 day-1 eugenol, respectively (Table 1).
Determination of brain serotonin (5-hydroxytryptamine, 
5-HT)
Equal volumes of brain homogenate and ice-cold 
HPLC-grade  methanol  were  mixed,  followed  by 
centrifugation at 4,000 g at 4 °C for 10 min (Z 36 HK high-
speed  centrifuge,  HERMLE  Labortechnik  GmbH, 
Germany). The supernatant was filtered through a 45 μm 
filter and then analysed by high performance liquid 
chromatography (Agilent 1100, Agilent Technologies, 
Waldbronn, Germany) (32). Samples (20 μl) were injected 
into the loop injector (Rheodyne 210A, USA). AQUA C18 
5 μm 150 mm x 4.6 mm column (Phenomenex, USA) was 
used. The mobile phase consisted of 20 mmol L-1 potassium 
phosphate (pH 3) and methanol (97:3 v v-1) and the elution 
flow rate was 1.5 mL min-1. Serotonin was detected using 
a UV variable wavelength  detector  (G1314A-1100 LC 
VWD, Agilent Technologies, Waldbronn, Germany)  and 
its concentration (ng mg-1 tissue) was calculated using a 
calibration curve of standard serotonin (Sigma Aldrich. St 
Louis, MO, USA).
Determination of dietary aluminium level and brain trace 
metals concentration
The wet digestion method was used for the analysis of 
dietary aluminium and trace metals [Iron (Fe), Zinc (Zn), 
and Copper (Cu)] in brain tissues (33). Briefly, one cerebral 
hemisphere of a rat brain (or 0.2 g diet) was incubated 
overnight at 40 °C in a screw-capped polypropylene tube 
with 0.8 mL concentrated nitric acid (RIEDEL-DE HAËN, 
Germany) and 0.2 mL concentrated sulfuric acid (Merck, 
Germany). The mixture was then heated at 70 °C for 2 h and 
105 °C for 1 h, yielding a clear yellow solution, and the 
digest was allowed to cool and then diluted to 3 mL with 




Fixed brain specimens were processed and embedded 
in paraffin. Serial four μm-thick sections were made, stained 
with haematoxylin and eosin (H&E) and examined by light 
microscopy.
Table 1 Average intake data of rats treated with aluminium with or without eugenol mixed in the diet
Groups
Average intake
Food consumption  




orally Eugenol  
(mg kg-1 b.w. per day)
(mg kg-1 b.w. per day)
Control 15.72±3.56 1.40 -- --
EUG 12.42±1.90 1.27 -- 480
AlCl3 15.61±1.83 1.56 17 --
EUG+AlCl3 14.22±0.80 1.55 17 580
Values are mean±SEM (n=10)
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Effect of eugenol and/or aluminium on brain TAS and 
LPO
Treatment with AlCl3  alone  resulted  in  a  significant 
reduction in brain TAS (29.42 %, p<0.001), along with a 
significant  rise  in  lipid  peroxidation  expressed  as MDA 
(50.42 %, p<0.002) compared with controls. In contrast, 
rats treated with AlCl3 and fed with eugenol-supplemented 
diets displayed a significant enhancement in brain 
endogenous TAS compared with AlCl3-treated rats 
(17.60 %, p<0.05) with a concomitant return to control 
MDA levels (Figure 1).
Effect of eugenol and/or aluminium on brain Casp-3 and 
TNF-α concentrations
Apoptosis was severely induced in the brain of AlCl3-
treated  rats  as manifested  by  sharp  parallel  significant 
elevations  in  Casp-3  (777 %,  p<0.001)  and  TNF-α 
(250.62 %, p<0.001) levels, compared with controls. On 
the other hand, co-administration of eugenol with AlCl3 
produced a marked significant reduction in Casp-3 
(56.67 %, p<0.001) and  TNF-α (41.05%, p<0.001) levels, 
compared with AlCl3-only-treated rats (Figure 2).
Effect of eugenol and/or aluminium on brain AChE 
activity and BDNF level
Rats intoxicated with AlCl3 displayed a sharp significant 
increase in the AChE activity (204.48 %, p<0.001) 
accompanied with a significant depletion in BDNF 
concentration (33.72 %, p<0.002), compared with controls. 
On the contrary, eugenol supplementation with AlCl3 
normalised brain BDNF level and significantly reduced the 
AChE activity (46.99 %, p<0.001), with respect to AlCl3 
treatment (Figure 3).
Effect of eugenol and/or aluminium on brain serotonin 
level
Subchronic toxic administration of AlCl3 to male rats 
significantly  suppressed brain  serotonin  level  (37.65 %, 
p<0.01) compared with controls, whereas co-administration 
of eugenol along with AlCl3 intoxication normalised brain 
serotonin concentration (Figure 4).
Effect of eugenol and/or aluminium on brain trace metal 
level
A significant elevation in Cu level was recorded in the 
brain of Al-intoxicated rats (21.02 %, p<0.05) compared 
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Figure 1 Effect of eugenol and/or aluminium on brain total 
antioxidant status (A) and lipid peroxidation (B) in rats. Values 
are mean ± SEM (n=7). Statistical analysis was performed using 
one-way ANOVA followed by the least significant difference (LSD) 
test. Significance: * p<0.05 versus Control, EUG and EUG+AlCl3 
groups; † p<0.05 versus Control, EUG, and AlCl3 groups
Figure 2 Effect of eugenol and/or aluminium on brain caspase 3 
(A) and tumour necrosis factor alpha (B) levels in rats. Values 
are mean ± SEM (n=7). Statistical analysis was performed using 
one-way ANOVA followed by the least significant difference (LSD) 
test. Significance: *p<0.05 versus Control, EUG and EUG+AlCl3 
groups; †p<0.05 versus Control, EUG, and AlCl3 groups
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with controls, whereas rats treated with AlCl3 and fed 
eugenol-supplemented diets manifested a return to normal 
Cu levels (Figure 5).
Histological findings
Microscopic examination of the brain cerebral cortex 
and hippocampus of control rats showed normal histological 
structure of the meninges, neurons of the cerebral cortex, 
and the small pyramidal cells of the pyramidal layer of the 
hippocampus (Figures 6 a and  6 b). Similar normal 
structures were revealed in the brain sections of eugenol-
supplemented rats. On the other hand, daily oral treatment 
of rats with AlCl3 for four successive weeks caused severe 
congestion in the blood vessels of the meninges, associated 
with marked karyopyknosis and degeneration of cerebral 
cortex neurons and the small pyramidal cells of the 
hippocampus (Figures 6 c and 6 d). Animals fed with 
eugenol-supplemented diets along with AlCl3 intoxication 
showed minimum damage to the brain tissue as demonstrated 
by reducing neuronal cell damage in the cerebral cortex and 
preservation of the small pyramidal cells of the hippocampus 
(Figures 6 e and 6 f).
Immunostaining of GFAP
Normal GFAP immunoreactivity was seen in astrocytes 
and glial fibres in the striatum of control (Figure 7 a) and 
eugenol-treated animals (Figure 7 b). On the other hand, 
decreased GFAP  immunoreactivity was  noticed  in  the 
striatum of AlCl3-intoxicated rats (Figure 7 c), whereas an 
apparent  restoration  of  GFAP  immunoreactivity  was 
observed in rats treated with AlCl3 and fed with eugenol-
supplemented diets (Figure 7 d). Scoring of neuronal 
damage is illustrated in Table 2.
DISCUSSION
The brain is especially vulnerable to oxidative stress, 
more than any other organ due to its large oxygen 
consumption, high lipid content, and low mitotic rate and 
antioxidant levels. The participation of free radical-induced 
oxidative brain cell injury in aluminium toxicity has been 
previously proposed (37-39). Our data demonstrated that 
sub-chronic aluminium administration to rats significantly 
reduced the brain total antioxidant status (TAS) with 
concomitant  enhancement  of  lipid  peroxidation  (LPO), 
verifying the oxidative stress-related changes that contribute 
to Al neurotoxicity.
Although Al cannot change its redox state, it exacerbates 
free radical damage and lipid peroxidation initiated by iron. 
This can be attributed to the fact that, like iron, Al binds to 
the  iron  regulatory  protein  (IRP), which  influences  the 
expression of iron-binding proteins. This causes further 
stabilisation of iron in its ferrous (Fe+2) state that promotes 
Fe+2-induced  LPO  by  the  Fenton  reaction, modifying 
therefore the biophysical properties of membranes. 
Oxidative damage resulting from aluminium and deregulated 
iron is indissociable in aluminium-loaded neurons, where 
their combined activity provides an oxidative environment 
(6, 11, 37).
In the present study, amelioration of the brain TAS with 
the depletion of LPO in Al-intoxicated rats simultaneously 
treated with eugenol suggests a lowered oxidative stress 
and protection of neuronal cell integrity. Eugenol has a 
broad range of biological actions in spite of its relatively 
simple molecular structure. Because of its hydrophobic 
property, orally administered eugenol seems to cross the 
blood brain barrier (BBB) and acts in situ (40) to inhibit 
lipid peroxidation (as a chain-breaking antioxidant) and to 
enhance endogenous antioxidant mechanisms (12, 14, 24). 
Eugenol possesses antioxidant property by virtue of its 
phenolic hydroxyl group in its structure that donates 
electrons to quench free radicals. It also prevents the 
oxidation of Fe2+ by H2O2 in the Fenton reaction, which 
generates hydroxyl radicals (•OH) involved in the initiation 
of lipid peroxidation (14).
Al disrupts the pro-inflammatory cytokine/neurotrophic 
balance that plays an important role in neurodegenerative 
disorders (38). Al intoxication in the current study induced 
Figure 3 Effect of eugenol and/or aluminium on brain 
acetylcholinesterase activity (A) and brain-derived neurotrophic 
factor level (B) in rats. Values are mean ± SEM (n=7). Statistical 
analysis was performed using one-way ANOVA followed by the 
least significant difference (LSD) test. Significance: *p<0.05 versus 
Control, EUG and EUG+AlCl3 groups; †p<0.05 versus Control, 
EUG, and AlCl3 groups
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brain apoptosis as demonstrated by increased brain Casp-3 
and TNF-α levels. This is verified histologically, as severe 
degenerations of cerebral cortex neurons and small 
pyramidal cells of the hippocampus were noticed. Induction 
of apoptosis and necrosis, as well as increased expression 
of inflammatory cytokines by Al, were previously reported 
in neuronal cells both in vitro (41) and in vivo (42). Owing 
to its affinity for negatively charged ligands, Al binds to the 
phosphate groups of nucleoside di- and triphosphates, DNA, 
RNA, and amino acids, influencing therefore energy 
metabolism, the functions of various protein kinases and 
phosphatases, the expression of various genes essential for 
brain functions, as well as the accumulation of highly 
phosphorylated cytoskeleton proteins. In addition, Al binds 
to various metal-binding proteins and influences homeostasis 
of other metals (such as Cu in the present study). These 
ultimate macromolecular alterations cause apoptotic death 
of neurons and glial cells (6).
The brain-derived neurotrophic factor (BDNF) plays 
an important role in regulating the survival and differentiation 
of selective populations of neurons during development. It 
is synthesised predominantly in the CNS by neurons, and 
is highly expressed in the hippocampus and cortex, two 
brain regions which are known to be important for learning 
and memory (43). BDNF has trophic effects on serotonergic 
(5-HT) neurons in the central nervous system. It has been 
reported that decreased expression of BDNF, which 
maintains normal neuronal circuits in the brain, appears to 
play an important role in the development of several 
neurodegenerative diseases. The reduction of BDNF 
following Al intoxication in the current study was 
previously reported (2, 9, 38). In addition, Al impairs 
various enzymes involved in neurotransmitters biosynthesis 
and one of its potential toxic mechanisms of action may 
include disruption in serotonergic neurotransmissions in 
the brain hippocampus (6, 44). Therefore, it is reasonable 
to suggest that Al suppressed brain serotonin concentration 
either directly, by reducing its biosynthesis, or indirectly, 
by downregulating BDNF level, which has trophic effects 
on serotonergic neurons.
The ability of eugenol to inhibit apoptosis and pro-
inflammatory cytokine secretion and subsequent protection 
of neuronal cells in the present study is related to its effect 
to counterbalance Al-induced oxidative stress and regulate 
the generation of the inflammatory cytokines. Eugenol was 
previously reported to inhibit the pro-inflammatory 
mediators (nitric oxide production and cyclooxygenase 2 
expression) in lipopolysaccharide-induced RAW264.7 
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Table 2 Histological and immunohistochemical alterations in the brain of rats treated with aluminium with or without eugenol mixed 
in the diet
Control EUG AlCl3 EUG+AlCl3
Cerebral Cortex Karyopyknosis of neuronal cells - - +++ +
Hippocampus Karyopyknosis of pyramidal cells - - +++ -
Striatum GFAP expression  +++ +++ + ++
Scoring key: Nil (-), mild (+), moderate (++), and severe (+++)
Figure 4 Effect of eugenol and/or aluminium on brain serotonin concentration in rats. Values are mean ± SEM (n=5). Statistical 
analysis was performed using one-way ANOVA followed by the least significant difference (LSD) test. Significance: *p<0.05 versus 
Control, EUG, and EUG+AlCl3 groups
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Figure 5 Effect of eugenol and/or aluminium on brain Fe, Zn, and Cu concentrations in rats. Values are mean ± SEM (n=3). Statistical 
analysis was performed using one-way ANOVA followed by the least significant difference (LSD) test. Significance: *p<0.05 versus 
Control, EUG, and EUG+AlCl3 groups
macrophages (45) and TNF-induced NF-kB activation in 
ML1-a cells (46). In addition, a direct neurotrophic effect 
of eugenol on BDNF was previously reported since the 
administration of eugenol in drinking water for two 
consecutive weeks to male mice induced BDNF gene 
expression in the hippocampus (47). Similarly, eugenol was 
able to reverse the stress-induced changes of serotonin level 
in all rat brain regions and such modulation in brain 
functions is attributed to the ability of eugenol to regulate 
voltage-gated cation channels and the release of 
neurotransmitters (48). Taken altogether, eugenol exerts a 
multitude of actions, either directly or indirectly, to restore 
a normal neurotrophic and serotonergic balance in the brain 
of Al-intoxicated rats. In accordance with the biochemical 
finding, histological examination revealed a neuroprotective 
potential of eugenol against brain-induced toxicity as 
demonstrated by reducing neuronal cell damage of the 
cerebral cortex and the preservation of small pyramidal 
cells of the hippocampus.
Acetylcholinesterase (AChE, EC 3.1.1.7) hydrolyses 
acetylcholine in cholinergic brain synapses and at 
neuromuscular junctions into choline and acetate. AChE is 
a significant biological component of the membrane that 
contributes to its integrity. Induction of the AChE activity 
causes faster acetylcholine degradation and consequent 
lowered stimulation of acetylcholine receptors, which 
produces a reduction of diverse cholinergic (learning and 
memory), as well as non-cholinergic (cell proliferation and 
neurite outgrowth) functions (12, 21). In the current study, 
sub-chronic administration of Al induced significantly the 
brain AChE activity. Comparable results were previously 
reported (2, 3).  Al exerts its cholinotoxic effects by blocking 
the provision of acetyl-CoA or by impairing the choline 
acetyltransferase activity (49). Also, Al can interact with 
plasma membrane lipids and affect the activity of membrane 
associated enzymes, including AChE. The increase in the 
Figure 6 Photomicrographs of rat brain sections stained with 
haematoxylin and eosin (bar=25 µm). The normal histological 
structure of the meninges (M) and cerebral cortex (CC) with intact 
neurons (a) and the pyramidal layer of the hippocampus (P), 
composed of 4-5 compact layers of small pyramidal cells (arrow) 
most with vesicular nuclei (b), were seen in control animals. AlCl3 
intoxication resulted in severe congestion in the blood vessels of 
the meninges, karyopyknosis of neuronal cells of the cerebral 
cortex (c) and pyramidal cells of the hippocampus, which showed 
darkened nuclei (d). Protection against AlCl3 brain toxicity with 
eugenol was evident by reducing karyopyknotic neuronal cells of 
the cerebral cortex (e) and the preservation of small pyramidal 
cells of the hippocampus (f)
34
brain AChE activity following aluminium exposure of rats 
was attributed to an allosteric interaction between Al with 
the peripheral anionic site of the enzyme molecule (50). 
The ability of eugenol to directly suppress the enhanced 
AChE activity following Al intoxication in the current study 
could be explained with the finding of an in vitro study that 
demonstrated a potential anti-cholinesterase property of 
eugenol (51). Similarly, eugenol was found to normalise 
the cortical AChE level in acrylamide-induced brain 
neuropathy in rats (21).
Astrocytes, the most abundant cell type in the brain, are 
responsible for providing nutrients to neurons. They are 
indispensable for the formation and stabilisation of 
synapses, as well as for the regulation of the concentration 
of various molecules supporting energy metabolism of 
neurons and are therefore critical for their survival (9, 52). 
Glial fibrillary acidic protein (GFAP), a structural protein 
composed of intermediate filaments synthesised in 
astrocytes, is a classical astrocyte marker. Decreased GFAP 
immunostaining in the brain of Al-intoxicated rats in the 
current study demonstrates the vulnerability of astrocytes 
to Al neurotoxicity, which contributes to neuronal loss. It 
has also been suggested that Al treatment impairs astrocytes 
to protect neurons from glutamate-induced excitotoxicity. 
The progressive accumulation of Al in astrocytes may 
protect neurons in early times after intoxication. 
Nevertheless, the pathological accumulation of Al may 
damage astrocytes at later time points (53, 54). A favourable 
effect of eugenol on basal glycogen synthesis in primary 
mouse astrocytes was previously demonstrated (52). 
Furthermore, a probable direct or indirect effect of eugenol 
to preserve brain astrocytes against Al-induced neurotoxicity 
is not excluded, which warrants further investigations.
In conclusion, the present study confirms the 
susceptibility of the brain to the toxic effect of increased 
oral exposure to aluminium in rats. The neurotoxicity of Al 
is likely to be the result of a combination of several 
mechanisms including oxidative brain injury and enhanced 
lipid peroxidation, disruption of neurotrophic, cholinergic, 
and serotonergic functions, and induction of apoptosis with 
ultimate neuronal and astrocyte damages. A neuroprotective 
role of eugenol against Al intoxication is verified through 
its antioxidant and antiapoptotic potential, as well as its 
neurotrophic property (Figure 8). Unfortunately, we were 
not successful in obtaining clear results concerning the 
measurement of Al concentration in the brain of rats by 
means  of  ICAP  spectrometry. Also,  eugenol’s  ability  to 
prevent Al bioaccumulation in the brain tissue may need 
further histochemical analysis (55). Since eugenol causes 
a significant delay in the neurodegenerative markers of the 
current Al-induced toxicity model, it represents a promising 
therapeutic adjuvant for brain disorders and related 
neuropathic conditions in further clinical investigations.
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Figure 7 Normal morphology and pattern of GFAP 
immunoreactivity were seen in astrocytes and glial fibres in the 
striatum of control (a) and eugenol-treated animals (b). A 
considerable decrease in GFAP immunoreactivity was observed 
in the striatum of rats intoxicated with AlCl3 (c), whereas an 
apparent increase in GFAP immunoreactivity was noticed in the 
striatum of rats treated with AlCl3 and fed with eugenol-
supplemented diets (d) (bar=20 μm)
Figure 8 A graphical scheme illustrating some of the proposed mechanisms involved in aluminium-induced brain toxicity and the 
probable actions by means of which eugenol exerts its neuroprotective effect
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štakori kojima je oralnim putem svakodnevno davan aluminijev klorid (84 mg kg-1 tjelesne težine) uz uobičajen režim 
prehrane ili uz prehranu obogaćenu eugenolom. Dnevna doza aluminija tijekom četiriju uzastopnih tjedana značajno je 
smanjila ukupni antioksidacijski status (TAS)(11,42 ± 0,31 μmol g-1 tkiva, p < 0,001) te je povećala lipidnu peroksidaciju 
(MDA)(32,55 ± 1,68 nmol g-1 tkiva, p < 0,002). Nadalje, tretman s Al potaknuo je aktivnost acetilkolinesteraze u mozgu 
(AChE)(46,22 ± 4,90 U mg-1 protein, p < 0,001) te povisio razine tumornoga nekroznog faktora alfa (TNF-α)(118,72 ± 
11,32 pg mg-1 protein, p < 0,001) i kaspaze 3 (Casp-3)(8,77 ± 1,26 ng mg-1 protein, p < 0,001), a značajno je smanjio 
razine neurotrofnoga moždanog faktora (BDNF)(82,74 ± 14,53 pg mg-1 protein, p < 0,002) i serotonina (5-HT)(1,54 ± 
0,12 ng mg-1 tkivo, p < 0,01). Isto tako, u usporedbi s kontrolnom skupinom koja nije bila tretirana, u strijatumu štakora 
tretiranih  aluminijem  primijećeno  je  imunobojenje  glijalnih  fibrilarnih  kiselih  proteina  (GFAP).  S  druge  strane, 
istovremenim uzimanjem eugenola i aluminija ponovo su uspostavljene normalne razine BDNF-a (108,76 ± 2,64 pg mg-1 
protein) i 5-HT-a (2,13 ± 0,27 ng mg-1 tkiva), a moždani je TAS povećan (13,43 ± 0,24 μmol g-1 tkiva, p < 0,05). Nadalje, 
istodobno su se razine TNF-α (69,98 ± 4,74 pg mg-1 protein) i Casp-3 (3,80 ± 0,37 ng mg-1 protein) značajno smanjile (p 
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